G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Revenue

G1 Therapeutics had revenue of $84.04M in the twelve months ending March 31, 2024, with 46.55% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.48M with 11.82% year-over-year growth. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.

• Revenue (ttm): $84.04M
• Revenue Growth: +46.55%
• P/S Ratio: 1.52
• Revenue / Employee: $840,410
• Employees: 100
• Market Cap: 128.09M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	82.51M	31.21M	60.84%
Dec 31, 2022	51.30M	19.83M	62.98%
Dec 31, 2021	31.48M	-13.81M	-30.49%
Dec 31, 2020	45.29M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	522.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.